This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dreher, M. R. Articles by Chilkoti, A. Search for Related Content PubMed PubMed Citation Articles by Dreher, M. R. Articles by Chilkoti, A.

Thermal Cycling Enhances the Accumulation of a Temperature-Sensitive Biopolymer in Solid Tumors

¹ Department of Biomedical Engineering, Duke University; ² Department of Radiation Oncology, Dulce University Medical Center, Durham, North Carolina; and ³ GE Healthcare, Waukesha, Wisconsin

Requests for reprints: Ashutosh Chilkoti, Department of Biomedical Engineering, Duke University, Box 90281, Durham, NC 27708. E-mail: chilkoti{at}duke.edu.

The delivery of anticancer therapeutics to solid tumors remains a critical problem in the treatment of cancer. This study reports a new methodology to target a temperature-responsive macromolecular drug carrier, an elastin-like polypeptide (ELP) to solid tumors. Using a dorsal skin fold window chamber model and intravital laser scanning confocal microscopy, we show that the ELP forms micron-sized aggregates that adhere to the tumor vasculature only when tumors are heated to 41.5°C. Upon return to normothermia, the vascular particles dissolve into the plasma, increasing the vascular concentration, which drives more ELPs across the tumor blood vessel and significantly increases its extravascular accumulation. These observations suggested that thermal cycling of tumors would increase the exposure of tumor cells to ELP drug carriers. We investigated this hypothesis in this study by thermally cycling an implanted tumor in nude mice from body temperature to 41.5°C thrice within 1.5 h, and showed the repeated formation of adherent microparticles of ELP in the heated tumor vasculature in each thermal cycle. These results suggest that thermal cycling of tumors can be repeated multiple times to further increase the accumulation of a thermally responsive polymeric drug carrier in solid tumors over a single heat-cool cycle. More broadly, this study shows a new approach—tumor thermal cycling—to exploit stimuli-responsive polymers in vivo to target the tumor vasculature or extravascular compartment with high specificity. [Cancer Res 2007;67(9):4418–24]

This article has been cited by other articles:

				M. R. Dreher and A. Chilkoti Toward a Systems Engineering Approach to Cancer Drug Delivery J Natl Cancer Inst, July 4, 2007; 99(13): 983 - 985. [Full Text] [PDF]